I Barshack
Overview
Explore the profile of I Barshack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halpert G, Katz I, Shovman O, Tarasov S, Ganina K, Petrova N, et al.
Clin Exp Immunol
. 2020 Oct;
203(3):400-408.
PMID: 33020923
Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease that leads to joint destruction and disability. Despite a significant progress in administration of biological agents for RA patients, there is...
2.
Nakache G, Yahav G, Siloni G, Barshack I, Alon E, Wolf M, et al.
J Laryngol Otol
. 2019 Jul;
133(8):696-699.
PMID: 31290382
Objective: To explore the use of fluorescence lifetime imaging microscopy in thyroid tissues, and to investigate how different thyroid lesions affect fluorescence lifetime. Method: Fluorescence lifetime measurements were taken of...
3.
Shemer A, Kivity S, Shovman O, Bashi T, Perry O, Watad A, et al.
Clin Exp Immunol
. 2018 Apr;
193(2):160-166.
PMID: 29698559
The role of helminth treatment in autoimmune diseases is growing constantly. Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease with challenging treatment options. Tuftsin-phosphorylcholine (TPC) is a novel helminth-based...
4.
Mizrahi A, Barzilai A, Gur-Wahnon D, Ben-Dov I, Glassberg S, Meningher T, et al.
Oncogene
. 2017 Sep;
37(2):218-230.
PMID: 28925390
Skin carcinogenesis is known to be a multi-step process with several stages along its malignant evolution. We hypothesized that transformation of normal epidermis to cutaneous squamous cell carcinoma (cSCC) is...
5.
Grossman C, Ben-Zvi I, Barshack I, Bornstein G
Scand J Rheumatol
. 2016 Jul;
46(3):222-225.
PMID: 27440169
Objectives: Temporal artery biopsy (TAB) is performed in patients suspected of giant cell arteritis (GCA). Inadequate TAB specimen length is considered a possible explanation for a negative biopsy in patients...
6.
Bashi T, Shovman O, Fridkin M, Volkov A, Barshack I, Blank M, et al.
Clin Exp Immunol
. 2015 Dec;
184(1):19-28.
PMID: 26618631
Treatment with helminthes and helminthes ova improved the clinical symptoms of several autoimmune diseases in patients and in animal models. Phosphorylcholine (PC) proved to be the immunomodulatory molecule. We aimed...
7.
Svetlicky N, Kivity S, Odeh Q, Shovman O, Gertel S, Amital H, et al.
Clin Exp Immunol
. 2015 Jul;
182(3):241-50.
PMID: 26132809
Administration of intravenous immunoglobulin (IVIg) is a recognized safe and efficient immunomodulation therapy for many autoimmune diseases. Anti-idiotypic antibody binding to pathogenic autoantibodies was proposed as one of the mechanisms...
8.
Grossman C, Barshack I, Bornstein G, Ben-Zvi I
Clin Exp Rheumatol
. 2015 May;
33(2 Suppl 89):S-84-9.
PMID: 26016755
Objectives: Temporal artery biopsy (TAB) is performed in cases of suspected giant cell arteritis (GCA), and is the gold-standard for diagnosis of the disease. Current American College of Rheumatology (ACR)...
9.
Carvalho S, Lindzen M, Lauriola M, Shirazi N, Sinha S, Abdul-Hai A, et al.
Oncogene
. 2015 Apr;
35(4):438-47.
PMID: 25915843
Growth factors of the epidermal growth factor (EGF)/neuregulin family are involved in tumor progression and, accordingly, antibodies that intercept a cognate receptor, epidermal growth factor receptor (EGFR)/ERBB1, or a co-receptor,...
10.
Golan T, Atias D, Barshack I, Avivi C, Goldstein R, Berger R
Br J Cancer
. 2014 Mar;
110(9):2269-76.
PMID: 24667644
Background: Challenges in developing drugs for pancreatic ductal adenocarcinoma (PDAC) include obtaining metastatic cancer tissue for research and validating biomarkers predicative for personalised therapeutic decisions. We have recently developed a...